Biotransformation and membrane transport in nephrotoxicity

W Dekant1, S Vamvakas

  • 1Institut für Toxikologie, Universität Würzburg, FRG.

Insights

This review details how the kidney is a common target for toxic substances (xenobiotics). It explains the molecular mechanisms behind selective kidney toxicity, focusing on accumulation and metabolism.

Area of Science:

  • Toxicology
  • Nephrology
  • Pharmacology

Background:

  • The kidney is a primary target organ for xenobiotic toxicity.
  • Understanding selective renal toxicity is crucial for predicting and preventing adverse drug reactions and environmental exposures.
  • Recent advances have elucidated molecular mechanisms underlying kidney-specific toxicity.

Purpose of the Study:

  • To review and summarize the current knowledge on the mechanistic basis of target organ selectivity for nephrotoxic xenobiotics.
  • To highlight the roles of renal physiology, transport mechanisms, and metabolic activation in selective kidney toxicity.

Main Methods:

  • Literature review of studies investigating xenobiotic-induced kidney toxicity.
  • Analysis of molecular mechanisms, including xenobiotic accumulation and metabolism.
  • Focus on specific classes of nephrotoxic compounds such as antibiotics, metals, polyhaloalkanes, and aminophenols.

Main Results:

  • Renal toxicity is often mediated by the accumulation of xenobiotics via renal transport mechanisms.
  • Active transport of metabolites formed in other organs contributes to kidney-specific toxicity.
  • Selective metabolism of xenobiotics to reactive electrophiles by kidney enzymes is another key mechanism.

Conclusions:

  • Selective renal toxicity of xenobiotics is multifactorial, involving uptake, transport, and metabolic activation within the kidney.
  • Understanding these mechanisms is essential for identifying high-risk compounds and developing protective strategies.
  • This review provides a comprehensive overview of the current understanding of xenobiotic nephrotoxicity.

Related Concept Videos

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...